Anna-luisa Luger
Dr. Senckenberg Institute Of Neurooncology
Frankfurt Am Main, HE, Germany
Frankfurt Am Main, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Lomustine with or without procarbazine in recurrent glioblastoma-A propensity score matching analysis.
Journal: Neuro-oncology advances
Published: February 20, 2026
Publisher Correction: State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
Journal: Neurological research and practice
Published: December 16, 2025
State of the art: glioma-associated epilepsy-bridging tumor biology and epileptogenesis.
Journal: Neurological research and practice
Published: September 06, 2025
Targeting glioblastoma mitochondrial metabolism with S-Gboxin induces cytotoxicity under conditions of the tumor microenvironment.
Journal: Cell death discovery
Published: August 27, 2025
Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.
Journal: Cell death discovery
Published: August 18, 2025
Glioma‑associated microglia and macrophages as a potential target for mTOR inhibition in glioblastoma.
Journal: Molecular medicine reports
Published: February 14, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment.
Journal: Journal of experimental & clinical cancer research : CR
Published: December 27, 2024
Superoxide dismutase 1 mediates adaptation to the tumor microenvironment of glioma cells via mammalian target of rapamycin complex 1.
Journal: Cell death discovery
Published: March 28, 2024
Outcome of glioblastoma patients after intensive care unit admission with invasive mechanical ventilation: a multicenter analysis.
Journal: Journal of neuro-oncology
Published: June 06, 2023
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.
Mammalian target of rapamycin inhibition protects glioma cells from temozolomide-induced cell death.
Journal: Cell death discovery
Published: May 19, 2023
Molecular matched targeted therapies for primary brain tumors-a single center retrospective analysis.
Journal: Journal of neuro-oncology
Published: March 17, 2022
Correction: Serine-dependent redox homeostasis regulates glioblastoma cell survival.
Journal: British journal of cancer
Published: August 07, 2021
Last Updated: 09/26/2026